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1. Introduction 
The primary aim of this chapter is to understand the importance of placement and 
maintenance of arteriovenous fistula (AVF) in the patients with advanced renal failure prior 
to the need for dialysis. Vascular access complications contribute significantly to the 
morbidity and mortality associated with end-stage renal disease patients on hemodialysis. 
The major concern this publication will address is that with the recommendation for an 
increased number of AV fistulas, we are faced with the fact that many fistulas fail, with 
limited data to understand complications of AVF specifically stenosis and thrombosis. 
Attempts to understand underlying mechanisms of stenosis and thrombosis will aide in 
access design, treatment options, and hence improve morbidity and mortality. 
The care and outcome of the patient with end-stage renal failure (ESRD) on chronic 
hemodialysis is dependent on their access. Although a variety of techniques have been 
developed for providing hemodialysis access, there have been no major advances in the past 
three decades. This contributes to the fact that hemodialysis access dysfunction is one of the 
most important causes of morbidity and mortality in the hemodialysis population. In 
addition, the expense of providing ESRD care in the US is a significant portion of the 
Medicare budget, totaling $23.9 billion in 2007, of which a significant portion is spent on 
placement and maintenance of vascular access (USRDS, 2009).  
The fistula provides the best outcome and can be placed with the least expense and 
complication rate when compared to a catheter or graft. Therefore, regional and network 
indicators promote the placement of AVF. Several recent initiatives have focused on 
vascular access and ways to improve outcomes. The National Foundation for Kidney-
Dialysis Outcomes Quality Initiative (K-DQOL), End Stage Renal Disease Clinical 
Performance Measures (CPM) and Fistula First Initiative (FFI) have provided guidelines that 
mandate fistula access in patients on hemodialysis (Vasquez, 2009). FFI, developed to 
promote fistula placement, had an initial goal of 40% of prevalent patients with fistula 
access. This goal was achieved in 2005, with a goal of 66% set for 2009. Nationwide, 
however, there are only 54.4% of prevalent hemodialysis patients with fistula access as of 
November, 2009, with the number of fistula access placements falling for the first time in 
2007 (USRDS, 2009). 
New insights into the care and maintenance of fistula access will help to ensure duration of 
long term access patency. With national initiatives to place more fistulas, the number of 
fistulas has and will continue to increase. There are gaps in knowledge as to surveillance, 
maturation, cannulation techniques and mechanism and treatment of stenosis and thrombosis. 
The following chapter on fistula access for hemodialysis will help to fill these voids. 
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2. Types of vascular access  
Permanent vascular access in the patient with ESRD on hemodialysis is provided through a 
central venous catheter (CVC), arteriovenous graft (AVG), or AVF. The central venous 
access is provided by a cuffed catheter placed subcutaneously in the internal jugular vein. 
The most frequent complications of CVC with significant clinical consequences include 
infection and thrombosis; therefore this access is not a recommended option for permanent 
vascular access. An AVG is placed if the venous or arterial supply is inadequate. It is created 
by insertion of a synthetic conduit usually polytetrafluororthylene between an artery and 
vein. AV grafts have a high rate of thrombosis and infection with an average survival of 
only 2-3 years ( KDQOL, 2006). An AV fistula is created by a surgical anastomosis between 
and artery and vein. When a fistula is created the vein and artery may be in their normal 
positions, or the distal end of the vein is moved to a position that is better located for 
cannulation (vein transposition). A translocation is done when the entire vein is moved from 
one anatomic location to another requiring an arterial and venous anastomosis. 
The fistula with the best outcome is the lower arm radiocephalic (RCF); however this access 
often fails to mature in the elderly patient with underlying vascular disease, particularly in 
diabetics (Miller,1999; Rodriquez, 2000). The second recommended fistula is the upper arm 
brachiocephalic fistula (BCF). This type of fistula is being placed with increased frequency 
because of the high failure rate of RCF. The third recommended fistula is the brachiobasilic 
fistula (BBF), which usually involves a two step surgical procedure and may be difficult to 
cannulate given the medial location of the basilic vein. 
2.1 Radial-cephalic fistula 
The RCF was the first fistula designed in 1966 by Brescia (Brescia, 1966). The RCF is created 
by an anastomosis between a radial artery and a cephalic vein usually with a transverse 
 
 
Fig. 1. Radial-cephalic fistula. Figure reprinted by permission from Macmillan Publishers 
Ltd: Kidney International, 62, 2002 
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incision at the wrist (Fig 1). This access is easy to place and once mature and used for 
dialysis has a low complication rate. The classic Cimino fistula is constructed with a side-to 
side anastomosis but this design may lead to venous hypertension. Therefore an end-to-side 
anastomosis is commonly used. The most frequent clinical problem is that this access has a 
higher primary failure rate when compared to BCF or BBF (Miller, 1999). However, if a RCF 
matures, the 5 to 10 year cumulative patency rate is 53 and 45 percent respectively 
(Bonalumi, 1982, Rodriguez, 2000). Placement of a lower arm fistula is desirable as it 
preserves the upper arm for future use. 
2.2 Brachial-cephalic fistula  
The BCF is a suitable second choice for access (Reubens, 1993). The cephalic vein in the 
upper arm is larger with increased flow as compared to the lower arm. The anastomosis for 
a BCF is usually in the antecubital fossa between the brachial artery and cephalic vein  
(Fig 2). The location of the BCF enables ease of cannulation with the benefit of a large 
surface area. The major complication with a BCF is the steal syndrome (see complications) as 
compared to RCF or BBF. In a retrospective review of 2,422 patients with vascular access, 
the BBF had a superior patency rate in diabetic pateints when compared to diabetic pateints 
who had a RCF (Papanikolaou, 2009). The authors even went so far as to argue that the BCF 
may be the best access option for the older diabetic patient on hemodialysis. 
 
 
Fig. 2. Brachial-cephalic fistula. Figure reprinted by permission from Macmillan Publishers 
Ltd: Kidney International, 62, 2002 
2.3 Brachial-basilic fistula  
The BBF is the third choice for fistula placement (Dagher, 1976). Because the basilic vein is 
less accessible to venipuncture it tends to be better preserved and less involved with 
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traumatic post-phlebitic changes when compared to the cephalic vein. When the BBF is 
placed more surgical skill is required with an initial anastomosis deep between the brachial 
artery and basilic vein (Fig 3). The BBF is left to mature for two months and then a second 
surgical procedure is preformed to “lift” the vein to allow ease of cannulation. The anatomic 
location of this fistula is often located in a position which is difficult to cannulate. Overall, 
the failure rate of the BBF is worse than BCF or RCF (Taghizadeh, 2003).  
 
 
Fig. 3. Brachial-basilic fistula. Figure reprinted by permission from Macmillan Publishers 
Ltd: Kidney International, 62, 2002 
3. Complications of fistula access 
Even though complications of fistula access are far less than a graft or a catheter, they do 
occur and need to be addressed. Complications occur in approximately one-third of fistulas 
and include: aneurysms, infection, stenosis, thrombosis, steal syndrome and heart failure. 
These complications have historically been classified as early and late failure. The etiology 
of both early and late are somewhat similar because if the cause is not diagnosed early on it 
may progress and lead to late access failure. Fistula failure may also be classified as primary 
defined as a fistula which fails prior to cannulation or secondary defined as failure after a 
radiologic intervention such as angioplasty or stent or surgical revision. 
3.1 Early failure/complications  
Early failure of an AVF is defined as a fistula which never matures or is unable to be used by 
three months of time. It is well known from several studies that there is a significant 
primary failure rate for all AV fistulas that are placed (Schild,2004; Biuckians,2008; Dember 
2008). Causes of early fistula failure are due to inflow problems from inadequate arterial 
supply, anastamotic stenosis which may result from trauma during creation, or outflow 
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problems of the venous segment. Outflow problems may occur because of underlying 
fibrosis of the vein. Other factors which contribute to the primary failure of fistulas include 
demographic factors such as age, obesity, non-white ethic group, female sex , history of 
diabetes or peripheral vascular disease (Lok, 2006; Huijbregts, 2008) The size of the 
underlying vein may also influence the ability of a fistula to mature. A cephalic vein 
diameter of less than 2.0 mm on ultrasound in the forearm and less venous distensibility 
increases the risk of primary failure (Silva, 1998). 
A cause of poor maturation is the development of collateral circulation. Often times a fistula 
is placed and when developing, collateral vessels may form which decrease the amount of 
flow through the designated vein to be used for cannulation. The physical exam may often 
help diagnosis this problem as you may palpate extra accessory vessels with an apparent 
augmentation in the vein when it is occluded. Small assessory vessels less than one-forth the 
diameter of the main AVF are likely to be insignificant. If a fistula is not maturing by 6 
weeks, many algorithms suggest a vengram by 6 weeks. If collateral vessels are identified 
they may be coiled by interventional radiology techniques or ligated by surgical techniques 
(Rodriguez, 2000). 
Prevention of early fistula thrombosis with pharmacologic intervention has been the subject of 
several recent trials, which have shown only minimal effect. The Dialysis Outcomes –Practice 
Patterns Study (DOPPS) noted a lower risk of failure of established fistulas in patients who 
used aspirin consistently over a year (Hassegawa, 2008). The Dialysis Access Consortium 
Fistula Trial (DAC) was a multi-center trial which compared the effects of the anti-platlet agent 
Clopidrogrel with placebo on early fistula failure. The proposed sample size was 1284, but the 
study was terminated after enrollment of 877 patients as interim data analysis showed that 
Clopridrogel reduced the risk of fistula thrombosis by 37% (Dember, 2008). In the DAC study 
61% of newly created fistulas failed. These findings and others have shown a primary failure 
rate of 31-61% (Schild,2004; Biuckians,2008; December 2008). This suggests that failure of the 
fistula to mature is the main obstacle to successful fistula use. 
3.2 Late failure/complications 
Late failure of the fistula is defined as occurring greater than three months after creation and 
is often due to outflow stenosis. Venous stenosis occurs less frequently in AVF when 
compared to AVG, but nonetheless it is a common cause of AVF failure. Venous stenosis is 
usually detected clinically by symptoms of swelling of the extremity, prolonged bleeding 
post dialysis, difficulty cannulation or poor clearance. When these symptoms develop, the 
patient may be sent for an ultrasound for diagnosis or more commonly an interventional 
venogram. The venogram is desirable as a patient may have the venogram/angioplasty as a 
treatment option during the same procedure. 
The most common anatomic location for an outflow stenosis in a RCF is 3 cm from the 
arteriovenous anastomaosis (Rajan, 2004). Outflow stenosis in RCF may be treated 
successfully by angioplasty with favorable primary and secondary patency rates (Rajan, 
2004). Inflow lesions from inadequate arterial flow are often detected by a negative arterial 
pressure during hemodialysis and by physical examination using pulse augmentation. An 
arterial lesion may be present in 15-30% of fistulas (Leon, 2008). This type of lesion also is 
successfully treated by angioplasty or surgical revision (Turmel-Rodrigues, 2000).  
One of the leading causes of failure of BCF is due to stenosis in the cephalic arch, which is 
the final bend in the cephalic vein prior to entry into the axillary vein (Fig 4). Cephalic arch 
stenosis (CAS) is found to occur in up to 77% of patients with BCF compared to 30% of 
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patients with RCF with an average clinical significance at 2 years necessitating a venogram 
with intervention. The risk of development of CAS is less in diabetics for unclear reasons 
(Hammes, 2008). The BCF has been shown to be a superior access in older diabetic patients 
(Papanikolaou, 2009). Once CAS occurs it leads to head and neck swelling, high venous 
pressures and resultant thrombosis with complex treatment options. The arch is elastic, 
resistant to repeated angioplasty and often requires stent placement resulting in further 
stenosis (Hammes, 2008).  
 
 
Fig. 4. Radiograph of Cephalic arch represented by arrow; C is the cephalic vein;A is the 
axillary vein 
3.2.1 Aneurysms  
The incidence of aneurysm formation in fistulas varies in studies from 5-7% (Lo, 2007). A 
traditional definition of an aneurysm is that it is considered true if it involves all layers of 
a venous wall or false if the wall is lined by thrombus or fibrous tissue. Aneurisms form 
for many reasons which include repeated cannulation at repetitive sites or altered 
turbulent blood flow from stenosis. As aneurysms are both a physiologic and cosmetic 
complication that may lead to the need for surgical revision and subsequent failure an 
approach to address aneurysms should be developed. Moreover, if a thrombosis occurs 
and significant aneurysm is present, the clot burden may be large and the thrombectomy 
procedure may be difficult. Aneurysms may also lead to an increased infection risk and 
prolonged bleeding post dialysis. 
The treatment of aneurysms is prevention and if they form surgical correction. Preventative 
measures start with careful cannulation techniques (see cannulation techniques). Surgical 
options for correction include longitudinal stapling to reduce the lumen, open placation, 
excision with primary anastomosis, excision with interposition of prosthetic graft, and 
ligation (Pierce, 2007; Lo, 2007; Georgiadis, 2008). All of these techniques have been used 
with success and a decision for surgical treatment should be made on a case-by-case basis. 
3.2.2 Steal syndrome 
Steal syndrome is defined as distal hypoperfusion of the extremity in patients with severe 
peripheral vascular disease due to shunting of arterial blood flow into the fistula (Leon 
2007). Reverse flow occurs if the diameter of the fistula opening is greater than the diameter 
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of the feeding artery. Symptomatic steal occurs when there is a failure of adequate collateral 
flow and/or excessive blood flow. This problem complicates approximately 3-5% of fistulas 
and grafts. It is likely to occur more frequently with BCF (6%) verses RCF. Hand ischemia 
from steal syndrome may require distal revascularization with interval ligation (DRIL) 
procedure or complete ligation in severe cases. The DRIL procedure was first proposed by 
Harry Schanzer in 1988 (Schanzer, 1988). A short distal bypass is created and the artery just 
distal to the AV anastomosis is ligated. The DRIL procedure has been used successfully to 
relieve the ischemic symptoms in a significant number of patients with steal syndrome 
(Waltz, 2007). 
3.2.3 Infection 
The incidence of infection of an AVF is relatively low given that the native vein is used as a 
conduit. Predisposing factors to infection include: inadequate skin disinfection prior to 
cannulation, pseudo aneurisms, perifistular hematomas (often due to inappropriate 
cannulation), puritis with skin excoriation over needle sites, or the use of the fistula for IV 
drug use. Infection occurring in native fistulas can usually be treated with intravenous 
antibiotics and, if necessary surgical drainage. 
3.2.4 Cardiac failure  
AVF creation causes an increased blood flow and resultant cardiac output, Creation of a 
fistula is associated with a 15% increase in cardiac output and 4% increase in left ventricular 
end-diastolic diameter There is also an observed increase in ANP and BNP (Iwashima, 
2002). These changes often go unnoticed, however high output failure from fistula access 
occurs in less than 1% of cases. The decision for permanent access placement in patients 
with category III or IV heart failure is challenging. Patients with ESRD in this subset should 
be considered for peritoneal dialysis. If this is not possible a lower arm fistula could be 
considered (decreased blood flow when compared to an upper arm fistula) with close 
monitor for worsened heart failure. 
3.2.5 Venous hypertension  
Venous hypertension in an extremity occurs because of incompetent venous valves or 
central venous stenosis. This problem may cause severe swelling in an extremity with 
associated complications of skin discoloration and thickening predisposing to infection. 
Doppler exam is used for diagnosis to demonstrate reversal of blood flow. Diagnosis and 
treatment with a venogram by an interventional radiologist may also be preformed. 
Treatment is aimed at correcting the underlying problem if present. Careful clinical 
practice includes obtaining a central venograms prior to fistula placement if there are 
clinical clues of venous hypertension such as, a history of ipsilateral catheter placement or 
dialated chest wall veins. 
3.2.6 Median nerve injury 
A very difficult problem with AVF access is median nerve injury. It may occur from 
ischemic injury from steal, compression of the nerve if there is extravasation of blood or 
local amyloid deposition in long term dialysis patients. The treatment is first to rule out 
vascular compromise and confirm diagnosis with an EMG. If traditional therapy to treat 
neuropathy does not resolve the pain, the fistula may need to be ligated. 
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4. Physiology of a fistula access 
The creation of a fistula results in blood flow from an artery to a vein that is inherently non-
physiologic in many ways. The initial flow rate in the radial artery of 20-30 mL/min 
increases to 200-300 mL/min immediately after creation of an AV fistula, reaching flow 
rates of 600-1200 mL/min after maturation (Wedgewood, 1984). In addition, the blood flow 
in the vein is not pulsatile prior to fistula insertion, whereas it is after the fistula is created. 
High fistula blood flow, a prerequisite for venous dilation and a requirement for easy 
cannulation and adequate dialysis, is accompanied by high arterial pressure being 
transmitted to the vein. This intense increase in flow rate and pressure has a profound effect 
on the hemodynamics in the downstream vein (Albayrak, 2006). The dramatically increased 
arterial blood flow at the time of fistula creation ultimately leads to an overall increase in 
shear stress, early on an observed low shear stress is evident which is thought to contribute 
to intimal hyperplasia and resultant venous stenosis and ultimate thrombosis. 
5. Mechanism of stenosis and thrombosis 
The mechanism responsible for the development of intimal hyperplasia and resultant 
venous stenosis is poorly understood. Stenosis, leading to thrombosis may require repeated 
procedures to maintain access patency and is the number one contributor to access failure. 
Several factors contributing to the development of intimal hyperplasia include: endothelial 
cell (EC) dysfunction from high blood flow and resultant shear stress; underlying histology 
of the vein; geometry of the anastomosis and angles of bends in vein; vascular remodeling; 
oxidative stress and inflammatory mediators that result from the hemodialysis procedure 
itself, and rheological factors such as viscosity (Table 1). Future studies that look at these 
factors will guide treatment trials to improve outcomes. 
 
Shear Stress 
Histology 
Geometry 
Vascular Remodeling 
Oxidative Stress 
Rheology 
Table 1. Factors influencing Intimal Hyperplasia 
5.1 Shear stress 
When a fistula is created a vein is subjected to intense arterial pressure and flow. A vein is 
asked to behave as an artery perhaps without the anatomic make-up to undergo 
remodeling. The anatomy and physiology in a native artery is a constructive model to 
understand the mechanism of stenosis as it applies to venous stenosis in an AVF. A blood 
vessel is made of endothelial cells (EC) which form the lining of the vessel. These cells are 
normally aligned longitudinally. Vascular smooth muscle (VSM) cells align around the EC 
circumferentially. An arteriole has a thicken VSM layer when compared to a vein. Blood 
flow exerts pressure on the EC in a perpendicular direction. Shear stress is the frictional 
force per unit area from flowing blood which acts parallel to the EC that line the vessel. In 
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straight regions of vessels, blood flow is in the same direction (laminar) and EC are 
quiescent with high laminar shear stress and resultant low oxidative stress, cell turnover 
and permeability. When a fistula is created blood vessels divide or curve and complex flow 
patterns may develop. When this happens EC are subjected to disturbed shear stress with 
higher levels of oxidative stress and inflammation which may result in vascular remodeling 
(Hahn, 2009). 
The anastomosis of the fistula is also important to the development of intimal hyperplasia. 
The primary mode of failure of a fistula access relates to outflow stenosis caused by 
anastomotic intimal hyperplasia. When an anastomosis is created, the trauma causes 
activation of chemotactic factors which result in smooth muscle migration from the media to 
the intima. The resultant EC dysfunction with abnormal NO production may cause 
dysregulation of vascular tone. Smooth muscle cells continue to migrate and proliferate with 
resultant intimal hyperplasia. The end result may be decreased anastomotic compliance (Lin 
2005). 
This schematic of this process eventually leading to fistula failure is depicted in Figure 5. 
When a fistula is placed there is a bend or curve created at the anastomosis. This causes a 
turbulent blood flow, injury to EC, decreased WSS and resultant intimal hyperplasia. There 
is flow restriction that results and eventual worsened intimal hyperplasia that leads to 
further flow restriction with the end result of stenosis. The stenotic surface leads to 
heamostasis and further thrombus formation. Ultimately the fistula fails as a consequence of 
the stenosis. 
 
 
Decreased 
WSS  
Fistula 
Failure  
Fistula 
Creation 
Anastomosis  
Flow 
Recirculation  
Intimal 
Hyperplasia
 
Stenosis 
High   
WSS  
EC 
Denudation  
Thrombus  
 
Fig. 5. Proposed cycle of fistula creation which eventually leads to intimal hyperplasia and 
fistula failure 
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5.2 Histology of the vein 
Arterial and venous dialation is critical for fistula maturation. There is no exact definition of 
fistula maturation, but it is considered mature when it can routinely be cannulated with 2 
needles and deliver a minimum blood flow (typically 350 to 450 mL/min) for a total 
duration of dialysis ( usually 3-5 hours). Impaired dialation may be due to both structural 
and or functional factors. Pathologic analysis of the muscular artery and cephalic vein from 
patients with ESRD have demonstrated neo-intimal thickening (Wall, 2006). Other findings 
include increase radial artery intimal-media thickness which is correlated with decreased 
fistula maturation (Dixon, 2009). Many of these pathologic findings are present in the vein at 
the time of fistula placement and influence the outcome of the fistula. 
5.3 Geometry  
A fistula is created by an anastomosis creating a curve or bend to the vessel. The 
anastomosis is usually by and end-to-side design but occasionally by a side-to-side design. 
This creates a change from laminar flow to turbulent flow and as described above, the result 
is increased shear stress on EC with resultant intimal hyperplasia. This process may also be 
occurring in native conditions such as occurs in the cephalic arch. Hammes reviewed 45 
venograms from BCF access and made measurements of the cephalic arch angle (global) and 
minimum radius of curvature and cephalic vein diameter (local measurements). Both  
global and local measurements showed evidence of having two distinct arch angles. 
Diabetics more commonly had a wider angle and less evidence of cephalic arch stenosis 
whereas non-diabetics had a wider angle and increased incidence of stenosis. (Hammes, 
2009). These findings suggest that geometry influences hemodynamics and resultant 
stenosis. 
5.4 Vascular remodeling 
Vascular remodeling, first described by Glagov in 1987, refers to the ability of a vessel to 
change dimensions by vasoconstriction or vasodilatation, adjusting to flow changes to 
prevent stenosis. He reported that atherosclerotic arterial lumen narrowing was not simply 
the result of enlargement of the plaque lesion, but rather the vascular failure of the vessel to 
remodel to maintain a diameter so as not to inhibit blood flow (Korshunov, 2007). In a 
fistula, the vein and artery must remodel to a certain degree so as not to develop intimal 
hyperplasia or fibrosis.  
In experimental models, when a fistula is first created, the cross-sectional area of the arterial 
wall increases with increased elastin, collagen and possibly smooth muscle cells( Driss, 
1997). In human studies, this does not occur, but after a year, the artery appears to thicken 
circumferentially which may lead to defective remodeling (Dammers, 2005). Venous 
dialation occurs rapidly after the anastomosis due to increased areterial pressure and 
continues to dilate over several weeks attaining blood flow by 4-6 weeks (Dixon, 2006). Over 
time, venous thickening occurs and is characterized by intimal hyperplasia, smooth muscle 
cell proliferation and increased extracellular matrix production (Nath, 2003). If intimal 
hyperplasia develops and leads to clinically significant stenosis a venogram with 
angioplasty is usually preformed to dialate the venous stenosis. Early on the lesion may be 
responsive to angioplasty. At this point, there is no doubt remodeling taking place that is 
maintaining the diameter of the lumen. Over time with repeated use of the fistula, trauma 
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and resultant inflammation may develop with repeated interventional angiography 
ultimately leading to fibrosis of the vein and eventual access failure.  
5.5 Oxidative stress and inflammation  
When a fistula is placed, matures and is cannulated for hemodialysis an inflammatory 
environment is created which leads to changes in vascular biology that may contribute to 
the development of intimal hyperplasia. EC dysfunction from altered shear stress as 
described above leads to release of nitric oxide and arterial dialation in response to increase 
flow rates (Dixon, 2009). It has been observed that when arterial dialation occurs, there is 
continued increase in shear stress that does not always normalize, suggesting that arterial 
adaptation to fistula creation may be incomplete. (Damers, 2005) 
With evidence of histologic inflammation, there is upregulation of numerous cytokine and 
genes the cause smooth muscle proliferation and collagen deposition. Histologic injury to 
the vein is mediated by easly upregulation of mRNA for MCP-1, PAI-1, and endothelin -1 
and later upregulation of mRNA for fibrogenic cytokine, transforming growth factor–B. 
(Dixon 2009). These studies demonstrate that the vein responds to pressure and shear stress 
by upregulating genes that lead to NIH. Future attempts to decrease these inflammatory 
mediators with pharmacologic therapy may prove effective to avert the inevitable intimal 
hyperplasia and fibrosis that may develop. 
5.6 Rheology 
Another significant factor which affects blood flow through a fistula is rheology, the 
characteristics of blood cells. The size, shape, deformeability, aggregation and whole blood 
viscosity (WBV) of blood have been shown to affect circulatory hemodynamics (Cho, 2008). 
Increased WBV may be detrimental causing increased peripheral resistance and sludging in 
post capillary venules (Pop, 2002). Patients with a history of peripheral vascular disease and 
diabetes, which are common in patients with ESRD, are associated with increased WBV. 
Over half of patients with ESRD have underlying diabetes and hypertension and it is 
predicted that these patients have elevated WBV.  
 Given that elevated WBV causes impaired circulation, it is likely that rheology, specifically 
WBV, contributes to the development of fistula stenosis and thrombosis. This area is the 
subject of future investigation. 
6. Cannulation techniques for AVF  
When a patient begins hemodialysis the start of hemodialysis is accompanied with anxiety 
regarding the surgical placement of the access along with needle cannulation. Excessive 
dilation of the fistula may be of major concern for patients. These issues should be 
addressed through education and not prevent patients from receiving the benefits of a well 
functioning access. The education and timing of the access placement to coincide with the 
initiation of hemodialysis is of paramount importance. It is imperative that attention to the 
placement of dialysis access is discussed when it is determined that a patient will need 
chronic hemodialysis.  
Once an AVF is surgically placed, it usually takes two months for the vein to mature to 
allow for cannulation. Although some fistulas mature within weeks, others may require up 
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to 6 months before they provide reliable hemodialysis access so catheters may be removed. 
The timing of when to cannulate is determined by clinical examination. The vein should be 
palpable, visualized and long enough to accommodate two needles. The fistula should be 
within 1 cm of the skin surface in order for reliable cannulation. If the venous segment is too 
deep, a transposition may be preformed. There is consensus that fistulas should be l 
eft to mature for at least 30 days. In general cannulation before 2 weeks should be  
avoided. 
Accurate cannulation of the fistula by experienced personal is mandatory for successful 
outcomes. Trauma including laceration and infiltration of the vein may cause local damage 
making future cannulation difficult. It has been estimated that one infiltration may delay 
catheter removal by 3 months. Techniques for cannulation include rotation of sites or the 
buttonhole technique. The buttonhole cannulation method is gaining increased acceptance 
among patients as there is less pain with the needle stick and decreased long term risk of 
aneurism formation. 
6.1 Rope-ladder technique 
The rope and ladder technique is the traditional method for access cannulation. This was 
developed so as not to weaken the integrity of the vein with repeated cannulation. The 
fistula is thought of as a rope or ladder and the needles are placed one to two inches apart, 
similar to rungs on a ladder or knots in a rope. The site is left to heal prior to the subsequent 
cannulation. This technique is useful to prevent aneurysms and prolong the life of the 
fistula. Complications may arise if the same site is cannulated which may be the case if sites 
are limited and one site becomes easier to cannulate. 
6.2 Buttonhole technique 
The buttonhole technique was introduced in Poland over 25 years ago when dialysis 
supplies including AVF needles were limited (Twardowski, 1979). AVF needles were reused 
for multiple cannulations and become dull with repeated use. The “dull” needle would 
enter smoothly if the exact same cannulation site and angle was used. The buttonhole 
technique was used to successfully solve the dull needle problem, with this method, the 
needles are inserted at exactly the same spot at consecutive dialysis sessions, establishing a 
channel in the AVF. The procedure of the buttonhole cannulation involves: identifying an 
optimal site such as a long venous segment without previous trauma, removal of the scab 
from previous puncture site using an aseptic technique and cannulation of the fistula at 
exactly same angle (approximately 25º). Initially sharp needles are used but once the track is 
developed which usually takes 2 weeks a blunt needle is used. This method has gained wide 
acceptance among patients as there is less pain associated with the cannulation and a 
decreased incidence of aneurysms. The buttonhole technique is gaining widespread 
acceptance in patients who practice self-cannulation (Verhallen, 2007). It is a technique that 
promotes independent self-care. 
The main risk associated with buttonhole cannulation is infection. There may also be 
problems with “one-site-itis” which occurs if the same site is stuck technique include those 
with heavily scarred fibrous or a large amount of subcutaneous tissue in the upper arm. 
multiple times, the skin can become heavily scarred. Both infection or development of a 
fibrous track require placement of a new buttonhole.  
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6.3 Self cannulation 
Patients who are able to use self cannulation have excellent outcomes, establishing 
independence, confidence and less pain. The technique of self cannulation allows the patient 
to feel where to place the needles and with experience there is a lower risk of infiltrations. 
This is an excellent cannulation option for home hemodialysis. 
7. Routine surveillance  
While fistula access is recommended for all patients with ESRD on hemodialysis, 
complications such as stenosis and resultant thrombosis lead to access failure. Therefore, 
surveillance of hemodialysis access is mandated by regulatory agencies (NKF: K/DOQI, 
2006). Prior research attempts to substantiate a surveillance protocol for AV grafts have 
failed, showing no improvement in the outcome of thrombosis. There is a paucity of data on 
the benefit of surveillance for fistulas (Allon 2009). Once the factors that cause venous 
stenosis in fistulas are known, early detection provides the necessary framework to develop 
protocols to mitigate the onset of intimal hyperplasia. Treatment trials in future studies 
could then be initiated to change factors that contribute to venous stenosis. 
Although there is a lack of adequate surveillance methods to detect fistula stenosis prior to 
thrombosis, there are some clues in the physical exam that may prove helpful in clinical 
practice. The physical examination may be the best test as to fistula adequacy for dialysis. 
Pre-procedure physical examination has been shown to accurately detect significant venous 
stenosis. The pre-dialysis physical exam of the fistula to detect significant stenosis may 
include: inspection, palpation from the anastomosis all the way to the chest wall, and 
auscultation. The characteristics of the pulse such as pulsatile, normal or weak, and if the 
thrill or bruit is continuous or discontinuous should be noted. Pulse augmentation and arm 
elevation tests may also be preformed to detect inflow or outflow stenosis. These elements 
of the physical exam have been reproduced and substantiated to correlate with venous 
stenosis (Asif, 2007).  
8. Conclusions  
This chapter has reviewed important aspects of AVF access for patient with ESRD on 
hemodialysis. The current enigma is that with increased need for placement the failure rate 
is high. Multiple factors cause fistula failure including: underlying demographic variables, 
stress of the dialysis treatment itself, along with flow changes and characteristics as 
illustrated in Fig. 6. Careful research to identify a comprehensive understanding of these  
factors will enhance fistula maturation thereby improving the outcomes for patients with 
ESRD on hemodialysis. 
The AVF is by far the best access with the least risk of complications for patients with 
ESRD. If a patient starts hemodialysis with a mature fistula, their transition to renal 
replacement therapy occurs with less risk of morbidity and mortality. As more fistulas are 
being placed, there is an increased awareness of complications including venous stenosis. 
We need to review and improve the surgical techniques of fistula placement and 
maintenance while optimizing novel therapies that promote fistula maturation. The 
etiology of venous stenosis in an AVF is the subject of future investigation with treatment 
trials to follow. 
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Fig. 6. Factors contributing to fistula failure 
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